3 Clinical psychopharmacology3.3 Pharmacodynamics
3.3.6.5 Dopamine agonists
1 min read1 figure
Written by Resident Doctor Committee · Published
Drugs
Dopamine agonists act mainly at D2-family receptors and cause more hallucinations, sleepiness and impulse control disorders than levodopa.
Agent | Type | Notes |
|---|---|---|
Pramipexole, ropinirole | Non-ergot, D2 and D3 | Impulse control risk; pramipexole is renally cleared |
Rotigotine | Non-ergot patch | Delivers drug over 24 hours |
Bromocriptine, cabergoline | Ergot-derived | Fibrosis and valve risk; treat hyperprolactinaemia |
Apomorphine | Subcutaneous | Treats "off" periods; causes nausea |
Impulse control disorders
Dopaminergic drugs used for Parkinson's disease and restless legs can cause impulse control disorders by acting on mesolimbic reward pathways, which are rich in D3 receptors.
Common forms are pathological gambling, compulsive buying, hypersexuality and binge eating.
Punding is prolonged repetitive activity.
Dopamine dysregulation syndrome is compulsive overuse of dopaminergic medication.
Risk rises with total dopaminergic exposure, younger onset and a history of addiction, yet it can appear at low doses or without a dose change.
Patients often hide these behaviours out of pleasure, shame or poor insight, so ask specifically before treatment and at each review.
Other adverse effects
Hallucinations often start as a sensed presence or movement at the edge of vision before becoming formed people or animals.
Sudden sleep episodes come without warning, and patients affected should stop driving and seek licensing advice.
Psychosis
Agonists given for antipsychotic-induced hyperprolactinaemia can worsen psychosis, so review the antipsychotic with specialists instead.
In Parkinson's psychosis, NICE supports selected low-dose quetiapine or clozapine, with required monitoring.